Literature DB >> 30664949

Effects of Medical Cannabis on Use of Opioids and Hospital Visits by Patients With Painful Chronic Pancreatitis.

Trevor S Barlowe1, Jenna L Koliani-Pace1, Kerrington D Smith1, Stuart R Gordon1, Timothy B Gardner2.   

Abstract

Pain is the most common and most debilitating aspect of chronic pancreatitis and is difficult to treat.1-3 Clinical management of painful chronic pancreatitis includes abstinence from alcohol and tobacco products, analgesic medications (including opioids), antidepressant medications, and pancreatic enzyme replacement.4-8 Medical cannabis has been proposed as a therapy for chronic pain and has shown some efficacy in neuropathic and cancer pain. In this study, we investigated the efficacy of medical cannabis on pain control for chronic pancreatitis.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30664949     DOI： 10.1016/j.cgh.2019.01.018

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  9 in total

1.  Outpatient Pain Management in Children With Chronic Pancreatitis: A Scoping Systematic Review.

Authors:  Emily R Perito; John F Pohl; Caitlin Bakker; Matthew A Armfield; Bradley Barth; Addison Cuneo; Maria Mascarenhas; Megha Mehta; Sarah Jane Schwarzenberg
Journal:  Pancreas       Date:  2022-02-01       Impact factor: 3.327

Review 2.  The deleterious effects of smoking on the development and progression of chronic pancreatitis.

Authors:  Samuel Y Han; Darwin L Conwell; Philip T Diaz; Amy Ferketich; Christie Y Jeon; Dhiraj Yadav; Phil A Hart
Journal:  Pancreatology       Date:  2022-08-11       Impact factor: 3.977

3.  Acute pancreatitis as a rare adverse event among cannabis users: A systematic review.

Authors:  Vikash Jaiswal; Dattatreya Mukherjee; Nitya Batra; Fnu Ruchika; Ammu Thampi Susheela; Jia Ee Chia; Deblina Mukherjee; Sidra Naz; Aguilera-Alvarez Victor; Nishan Babu Pokhrel; David Song; Tasur Seen; Talal Almas; Mohanmad Abou Saleh; Amandeep Singh Bansrao; Emad Mansoor
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

4.  A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.

Authors:  Sebastian Jugl; Aimalohi Okpeku; Brianna Costales; Earl J Morris; Golnoosh Alipour-Haris; Juan M Hincapie-Castillo; Nichole E Stetten; Ruba Sajdeya; Shailina Keshwani; Verlin Joseph; Yahan Zhang; Yun Shen; Lauren Adkins; Almut G Winterstein; Amie Goodin
Journal:  Med Cannabis Cannabinoids       Date:  2021-02-25

5.  Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases.

Authors:  Rahul S Dalal; Sonali Palchaudhuri; Christopher K Snider; James D Lewis; Shivan J Mehta; Gary R Lichtenstein
Journal:  Inflamm Bowel Dis       Date:  2021-03-15       Impact factor: 5.325

6.  Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review.

Authors:  Babasola O Okusanya; Ibitola O Asaolu; John E Ehiri; Linda Jepkoech Kimaru; Abidemi Okechukwu; Cecilia Rosales
Journal:  Syst Rev       Date:  2020-07-28

7.  Medical Cannabis Certification Is Associated With Decreased Opiate Use in Patients With Chronic Pain: A Retrospective Cohort Study in Delaware.

Authors:  Alan Balu; Divya Mishra; Jahan Marcu; Ganesh Balu
Journal:  Cureus       Date:  2021-12-07

Review 8.  Considerations for Cannabinoids in Perioperative Care by Anesthesiologists.

Authors:  Krzysztof Laudanski; Justin Wain
Journal:  J Clin Med       Date:  2022-01-22       Impact factor: 4.241

9.  Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies.

Authors:  Atefeh Noori; Anna Miroshnychenko; Yaadwinder Shergill; Vahid Ashoorion; Yasir Rehman; Rachel J Couban; D Norman Buckley; Lehana Thabane; Mohit Bhandari; Gordon H Guyatt; Thomas Agoritsas; Jason W Busse
Journal:  BMJ Open       Date:  2021-07-28       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.